A case report of combined treatment of gilteritinib and LH-RH agonist for Fms-related tyrosine kinase 3 receptor mutation-positive acute myeloid leukemia and bone marrow metastasis of prostate cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2022-02, Vol.101 (2), p.457-458
Hauptverfasser:	Onaka, Takashi, Kato-Ogura, Aiko, Otsuka, Yasuyuki, Iwai, Fumie, Yonezawa, Akihito
Format:	Artikel
Sprache:	eng
Schlagworte:	Aniline Compounds - therapeutic use Bone Marrow Neoplasms - drug therapy Bone Marrow Neoplasms - genetics Bone Marrow Neoplasms - pathology Bone Marrow Neoplasms - secondary fms-Like Tyrosine Kinase 3 - genetics Gonadotropin-Releasing Hormone - agonists Hematology Humans Letter to the Editor Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Male Medicine Medicine & Public Health Middle Aged Mutation - drug effects Oligopeptides - therapeutic use Oncology Prostatic Neoplasms - drug therapy Prostatic Neoplasms - genetics Prostatic Neoplasms - pathology Pyrazines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!